HNRNPA2B1 and coronary artery disorder: Consistently, we found a trend toward higher expression of hnRNPA2B1 mRNA in patients with CAD than in controls (Fig. 4C). Additionally, we designed specific siRNAs targeting hnRNPA2B1 to investigate the role of hnRNPA2B1 in vitro.